The lancet oncology
-
The lancet oncology · Aug 2010
Randomized Controlled TrialMortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world. One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate. ⋯ The Swedish Cancer Society, the Swedish Research Council, and the National Cancer Institute.
-
The lancet oncology · Aug 2010
Comparative StudyBody-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants.
Excess bodyweight is an established risk factor for several types of cancer, but there are sparse data from Asian populations, where the proportion of overweight and obese individuals is increasing rapidly and adiposity can be substantially greater for the same body-mass index (BMI) compared with people from Western populations. ⋯ National Health and Medical Research Council of Australia, Health Research Council of New Zealand, and Pfizer Inc.